Prokaryotic expression, purification and identification of the N protein of middle east respiratory syndrome coronavirus

Chinese Journal of Microbiology and Immunology (China)

Volumn 34, Issue 10, 2014, Pages 764-769

  Wang, Yanqun ^a   Hao, Chunxu ^b   Deng, Yao ^a   Yang, Yang ^a   Zhao, Li ^a   Shen, Xiaoling ^b   Tan, Wenjie ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

Identification; Middle east respiratory syndrome coronavirus; N protein; Prokaryotic expression; Purification

Indexed keywords

EID: 84914096998     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0254-5101.2014.10.007     Document Type: Article

References (16)

1. Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med, 2012, 367(19): 1814-1820.
2. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus[J]. N Engl J Med, 2013, 369(5): 407-416.
3. Bermingham A, Chand MA, Brown CS, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012[J]. Euro Surveill, 2012, 17(40): 20290.
4. Chu DK, Poon LL, Gomaa MM, et al. MERS coronaviruses in dromedary camels, Egypt[J]. Emerg Infect Dis, 2014, 20(6): 1049-1053.
5. Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection[J]. Lancet Infect Dis, 2013, 13(9): 745-751.
6. Chan JF, Lau SK, Woo PC. The emerging novel Middle East respiratory syndrome coronavirus: the "knowns" and "unknowns"[J]. J Formos Med Assoc, 2013, 112(7): 372-381.
7. Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses[J]. Antiviral Res, 2013, 100(1): 286-295.
8. Reusken CB, Haagmans BL, Midler MA, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels; a comparative serological study[J]. Lancet Infect Dis, 2013, 13(10): 859-866.
9. Alagaili AN, Briese T, Mishra N, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia[J]. MBio, 2014, 5(2): e00884-14.
10. Corman VM, Miiller MA, Costabel U, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections[J]. Euro Surveill, 2012, 17(49): pii:20334.
11. Song F, Fux R, Provacia LB, et al. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies[J]. J Virol, 2013, 87(21): 11950-11954.
12. Lu L, Liu Q, Du L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread[J]. Microbes Infect, 2013, 15(8-9): 625-629.
13. Reusken C, Mou H, Godeke GJ, et al. Specific serology for emerging human coronaviruses by protein microarray[J]. Euro Surveill, 2013, 18(14): 20441.
14. Meyer B, Drosten C, Miiller MA. Serological assays for emerging coronaviruses: Challenges and pitfalls[J]. Virus Res, 2014, pii:S0168-1702(14)00125-7.
15. Che XY, Qiu LW, Pan YX, et al. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome[J]. J Clin Microbiol, 2004, 42(6): 2629-2635.
16. Perera RA, Wang P, Gomaa MR, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013[J]. Euro Surveill, 2013, 18(36): pii:20574.